14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.151 $0.151 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $0.120 $0.168
52 weeks $0.0471 $3.25

Historical Clovis Oncology prices

Date Open High Low Close Volume
Oct 25, 2019 $3.06 $3.16 $3.00 $3.00 2 449 774
Oct 24, 2019 $3.21 $3.29 $3.06 $3.09 2 805 747
Oct 23, 2019 $3.45 $3.48 $3.20 $3.20 2 191 464
Oct 22, 2019 $3.50 $3.60 $3.38 $3.44 2 498 620
Oct 21, 2019 $3.36 $3.60 $3.31 $3.44 1 644 998
Oct 18, 2019 $3.70 $3.75 $3.29 $3.34 3 353 938
Oct 17, 2019 $3.26 $3.76 $3.21 $3.66 3 911 067
Oct 16, 2019 $3.23 $3.32 $3.19 $3.20 1 860 692
Oct 15, 2019 $3.11 $3.33 $3.01 $3.21 4 092 436
Oct 14, 2019 $3.30 $3.36 $3.11 $3.12 2 080 853
Oct 11, 2019 $3.21 $3.37 $3.17 $3.28 3 162 875
Oct 10, 2019 $3.22 $3.40 $3.12 $3.17 3 589 083
Oct 09, 2019 $3.18 $3.27 $3.13 $3.19 4 359 954
Oct 08, 2019 $3.50 $3.55 $3.14 $3.16 4 160 941
Oct 07, 2019 $3.70 $3.71 $3.57 $3.60 2 373 450
Oct 04, 2019 $3.85 $3.89 $3.70 $3.71 2 104 919
Oct 03, 2019 $4.02 $4.08 $3.74 $3.86 2 982 906
Oct 02, 2019 $3.95 $4.13 $3.70 $4.05 2 722 332
Oct 01, 2019 $3.91 $4.22 $3.83 $4.00 2 810 789
Sep 30, 2019 $4.09 $4.13 $3.76 $3.93 4 081 234
Sep 27, 2019 $4.02 $4.33 $3.97 $4.00 4 320 370
Sep 26, 2019 $4.16 $4.24 $4.00 $4.01 2 405 976
Sep 25, 2019 $4.27 $4.43 $4.08 $4.18 2 701 235
Sep 24, 2019 $4.45 $4.45 $3.97 $4.27 6 227 575
Sep 23, 2019 $4.76 $4.87 $4.56 $4.59 3 366 295
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT